awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38363677-BB8A728F-E30F-423A-A6C1-E1C86D075CD4
Q38363677-BB8A728F-E30F-423A-A6C1-E1C86D075CD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38363677-BB8A728F-E30F-423A-A6C1-E1C86D075CD4
Therapeutic options in Charcot-Marie-Tooth diseases.
P2860
Q38363677-BB8A728F-E30F-423A-A6C1-E1C86D075CD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38363677-BB8A728F-E30F-423A-A6C1-E1C86D075CD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a499da83823b25385fe79c62136fb6d4d4bde7f
P2860
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A